Kali Inc., a US-based medical research company, has announced the launch of the new Kali Cannabis Therapies subsidiary, which will develop cannabis biotechnology treatment alternatives to chemical pharmaceuticals. Last month, it acquired NCM Biotech to include a patented cannabis extraction ...